New from #WorldwideCancer https://t.co/SRGf5DmTLZ Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
1,619 followers
975 followers
Post-allo stem cell transplant outcome determined by ASXL1, RUNX1, and TP53 genes in all MDS IPSS-R patient groups. https://t.co/YKccjdvNbz
975 followers
Poor outcome post transplant of MDS/AML with ASXL1, RUNX1, or TP53, independent of IPSS-R. https://t.co/YKccjdvNbz
3,688 followers
Mutations and alloSCT: The question is should we transplant pts with poor predicted outcomes based on genomics? https://t.co/QSvXCS3bmA